Although these three genes show mutations in a wide spectrum of neurological diseases such as epilepsy, autism spectrum disorder (ASD), and intellectual disability, two of those, SCN1A and SCN2A, are major ones (reviewed in Yamakawa, 2016; Meisler et al., 2021). This evidence concerns the gene SCN2A and epilepsy.